Wilson Sonsini Goodrich & Rosati advised TigaTx on the transaction. Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibody therapeutics, announced that it...
Epsilogen’s Acquisition of TigaTx
Riva Ridge Capital Management’s Acquisition of Internal Condom
Wilson Sonsini Goodrich & Rosati advised Clear Future, Inc. on the transaction, and Reinhart Boerner Van Deuren s.c. advised Veru Inc. Veru Inc. (NASDAQ: VERU), a...
Imperial Dade’s Acquisition of Harbour Food Service Equipment
Wilson Sonsini Goodrich & Rosati advised Harbour on the transaction. Imperial Dade, a leading North American distributor of foodservice packaging supplies, industrial products, and janitorial supplies,...
United Therapeutics’ Acquisition of IVIVA
Wilson Sonsini Goodrich & Rosati represented IVIVA in the transaction. United Therapeutics (Nasdaq:UTHR) announced it acquisition of all of the outstanding equity of IVIVA Medical, Inc., a...
Nature’s Toolbox’s $47.5 Million Series B Funding Round
Wilson Sonsini Goodrich & Rosati advised Nature’s Toolbox on the transaction. Nature’s Toolbox (NTx) announced the close of a $47.5 million Series B funding round led by...
PSG’s Growth Investment in 4me
Wilson Sonsini Goodrich & Rosati advised 4me on the transaction. 4me®, a SaaS-based IT Service Management (ITSM) and Enterprise Service Management (ESM) software vendor, has announced...
Elucidata’s $16 Million Series A Fundraising
Wilson Sonsini Goodrich & Rosati advised Elucidata on the transaction. TechBio company Elucidata announced that it has raised $16 million in a Series A fundraising, which...
Phantom Neuro’s $6 Million Seed Funding Round
Wilson Sonsini advised Investor Time BioVentures on the deal while WilmerHale represented Phantom Neuro. Phantom Neuro, the first-of-its-kind neurotech startup that delivers a low power, high...
VitroLabs’ $46 Million Series A Financing
Wilson Sonsini advised VitroLabs on the deal. VitroLabs Inc, a Bay-Area-based biotech company leading the development of a new scientific process to grow the world’s first...
Iterative Scopes’ $150 Million Series B Funding
Wilson Sonsini Goodrich & Rosati advised Iterative Scopes on the deal. Iterative Scopes, a pioneer in the development of precision-based gastrointestinal (GI) disease technologies and software,...
Addi’s $200 Million Equity and Debt Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian and Cuatrecasas advised Addi on the deal. Wilson Sonsini Goodrich & Rosati and Philippi Prietocarrizosa Ferrero DU & Uría...